The Influence of Diabetes on the Relationship between N-terminal Pro-B-type Natriuretic Peptide and Body Mass Index

被引:6
作者
Kim, B. H. [2 ,3 ]
Kim, I. J. [2 ]
Cho, K. I. [1 ]
Kim, S. M. [1 ]
Lee, H. G. [1 ]
Kim, T. I. [1 ]
机构
[1] Maryknoll Med Ctr, Dept Internal Med, Pusan 600730, South Korea
[2] Pusan Natl Univ, Coll Med, Pusan Natl Univ Hosp, Dept Internal Med, Pusan, South Korea
[3] Pusan Natl Univ, Med Res Inst, Pusan, South Korea
关键词
CONGESTIVE HEART FAILURE; OBESITY; DIABETES; BODY MASS INDEX; B-TYPE NATRIURETIC PEPTIDE; LEFT-VENTRICULAR HYPERTROPHY; HEART-FAILURE; EMERGENCY DIAGNOSIS; OBESITY; ECHOCARDIOGRAPHY; LIPOLYSIS; ADIPOSE; UTILITY; IMPACT; TISSUE;
D O I
10.1177/147323001003800519
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This study evaluated the influence of diabetes on the relationship between N-terminal pro-B-type natriuretic peptide (NT-proBNP) and body mass index (BMI). Simultaneous NT-proBNP and echocardiographic Doppler examinations were performed in 1117 patients with dyspnoea undergoing cardiac catheterization. Patients were divided into BMI >= 25 kg/m(2) (obese), 23 - 25 kg/m(2) (overweight) and < 23 kg/m(2) (non-obese) groups. In the 803 non-diabetic patients, mean plasma NT-proBNP levels in non-obese, overweight and obese patients showed a significant negative correlation with BMI (862.3 +/- 228.8 pg/ml, 611.5 +/- 149.7 pg/ml, 278.3 +/- 172.5 pg/ml, respectively). In the 314 patients with diabetes, there was no correlation between BMI and NT-proBNP. This study demonstrated that obese patients had reduced concentrations of NT-proBNP compared with non-obese patients, despite having higher left ventricular filling pressures. NT-proBNP was not reduced in obese patients with diabetes. These results suggest that factors other than cardiac status impact on NT-proBNP concentration.
引用
收藏
页码:1737 / 1748
页数:12
相关论文
共 50 条
  • [21] N-terminal pro-B-type natriuretic peptide in early and advanced phases of obesity
    Mangge, Harald
    Almer, Gunter
    Zelzer, Sieglinde
    Vasan, Ramachandran
    Kraigher-Krainer, Elisabeth
    Gasser, Robert
    Schnedl, Wolfgang
    Ille, Rottraut
    Wallner, Sandra
    Moeller, Reinhard
    Horejsi, Renate
    Weghuber, Daniel
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (09) : 1539 - 1545
  • [22] High N-Terminal Pro-B-Type Natriuretic Peptide: A Biomarker of Lung Cancer?
    Aujollet, Nathalie
    Meyer, Marjorie
    Cailliod, Romain
    Combier, Fanny
    Coignet, Yann
    Campard, Sebastien
    Facy, Olivier
    Bernard, Alain
    Girard, Claude
    CLINICAL LUNG CANCER, 2010, 11 (05) : 341 - 345
  • [23] The influence of body composition on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with acute coronary syndrome: a cohort study
    Huang, Fang-Yang
    Wang, Hua
    Huang, Bao-Tao
    Liu, Wei
    Peng, Yong
    Zhang, Chen
    Xia, Tian-Li
    Wang, Peng-Ju
    Zuo, Zhi-Liang
    Heng, Yue
    Liu, Rui-Shuang
    Pu, Xiao-Bo
    Gui, Yi-Yue
    Chen, Shi-Jian
    Zhu, Ye
    Chen, Mao
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [24] N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea
    Maeder, Micha T.
    Ammann, Peter
    Rickli, Hans
    Schoch, Otto D.
    Korte, Wolfgang
    Huerny, Christoph
    Myers, Jonathan
    Muenzer, Thomas
    SLEEP AND BREATHING, 2008, 12 (01) : 7 - 16
  • [25] N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea
    Micha T. Maeder
    Peter Ammann
    Hans Rickli
    Otto D. Schoch
    Wolfgang Korte
    Christoph Hürny
    Jonathan Myers
    Thomas Münzer
    Sleep and Breathing, 2008, 12 : 7 - 16
  • [26] N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Loss of Muscle Mass in Prevalent Hemodialysis Patients
    Ikeda, Misa
    Honda, Hirokazu
    Takahashi, Keiko
    Shishido, Kanji
    Shibata, Takanori
    PLOS ONE, 2016, 11 (11):
  • [27] The N-terminal pro-B-type natriuretic peptide as a predictor of disease progression in patients with pericardial effusion
    Hwang, Dae-Seong
    Kim, Shin-Jae
    Shin, Eun-Seok
    Lee, Sang-Gon
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 157 (02) : 192 - 196
  • [28] The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea
    van der Burg-de Graauw, N.
    Cobbaert, C. M.
    Middelhoff, C. J. F. M.
    Bantje, T. A.
    van Guldener, C.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2009, 20 (03) : 301 - 306
  • [29] The influence of age on the clinical implications of N-terminal pro-B-type natriuretic peptide in acute coronary syndrome
    Huang, Fang-Yang
    Huang, Bao-Tao
    Tsauo, Jia-Yu
    Peng, Yong
    Xia, Tian-Li
    Zhang, Chen
    Liu, Rui-Shuang
    Zuo, Zhi-Liang
    Wang, Peng-Ju
    Heng, Yue
    Liu, Wei
    Pu, Xiao-Bo
    Gui, Yi-Yue
    Chen, Shi-Jian
    Liao, Yan-Biao
    Zhu, Ye
    Chen, Mao
    INTERNAL AND EMERGENCY MEDICINE, 2016, 11 (08) : 1077 - 1086
  • [30] Comparison of the cardiac markers B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide
    Buchner, Stefan
    Jungbauer, Carsten
    Birner, Christoph
    Debl, Kurt
    Riegger, Guenter A.
    Luchner, Andreas
    BIOMARKERS IN MEDICINE, 2009, 3 (05) : 465 - 481